To support NMIN’s mandate to translate nanomedicines from the bench to the clinic, PharmaCore provides support for NMIN Investigators to translate nanomedicines, which have been fully characterized by the NanoCore, into clinical development candidates.
PharmaCore supports in vitro, in vivo studies as well as scale-up, stability testing and manufacturing needs to help exemplify commercial potential. By bringing together Nanomedicine Investigators both in academia and industry, PharmaCore helps identify the best potential nanomedicines for commercial development, facilitates collaboration and helps with the formation of companies.
PharmaCore’s expertise will provide NMIN investigators and others in the network with the means to successfully develop novel nanomedicines into the clinical development stage leading to commercialization.
PharmaCore: Preclinical Scale-up Manufacturing & Project Management Core Facility
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.